Incyte (INCY) Current Deferred Revenue (2010 - 2016)
Incyte (INCY) recorded Current Deferred Revenue of $2.87 million in Q3 2016, down 77.7% from $12.86 million a year earlier and down 52.9% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Current Deferred Revenue (2010 - 2016) Analysis & Trends
At the end of FY2015, Incyte reported Current Deferred Revenue of $12.51 million, down 2.9% from FY2014.
- Annual Current Deferred Revenue has declined for four straight years, with a five-year compound annual growth rate of -28.5% (FY2010 to FY2015).
- Across earlier years, Current Deferred Revenue came in at $12.88 million in FY2014 (-0.1%), $12.89 million in FY2013 (-80.5%), $66.08 million in FY2012 (-1.3%) and $66.97 million in FY2011 (unchanged).
- The Q3 2016 figure is the lowest quarterly Current Deferred Revenue in data going back to Q4 2010.
- On a year-over-year basis, Current Deferred Revenue has declined for 16 consecutive quarters, with an average decline of 20.2% over the last eight quarters.
- Over the past five years, the year-over-year decline in Current Deferred Revenue ranged from 0.0% (Q3 2012) to 80.5% (Q4 2013).
- Per Business Quant, the preceding three quarters came in at $6.08 million (Q2 2016), $9.3 million (Q1 2016) and $12.51 million (Q4 2015).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Incyte | 24.39 Bn | 9.33 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2016 | 2.87 Mn |
| Jun 30, 2016 | 6.08 Mn |
| Mar 31, 2016 | 9.30 Mn |
| Dec 31, 2015 | 12.51 Mn |
| Sep 30, 2015 | 12.86 Mn |
| Jun 30, 2015 | 12.86 Mn |
| Mar 31, 2015 | 12.86 Mn |
| Dec 31, 2014 | 12.88 Mn |
| Sep 30, 2014 | 12.88 Mn |
| Jun 30, 2014 | 12.89 Mn |
| Mar 31, 2014 | 12.89 Mn |
| Dec 31, 2013 | 12.89 Mn |
| Sep 30, 2013 | 25.50 Mn |
| Jun 30, 2013 | 39.03 Mn |
| Mar 31, 2013 | 52.55 Mn |
| Dec 31, 2012 | 66.08 Mn |
| Sep 30, 2012 | 66.97 Mn |
| Jun 30, 2012 | 66.98 Mn |
| Mar 31, 2012 | 66.98 Mn |
| Dec 31, 2011 | 66.97 Mn |
API Access
Incyte Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();